Closing the gap between the lab and the market
Universities produce brilliant, unmonetized ideas. Manufacturers have the infrastructure to productize them. Lab-to-Market uses AI to connect the two — generating business models and product innovations that benefit the whole of society.
Academic research
We map departments, research groups and papers to surface ideas that never reach production.
AI matchmaking
Our model reads the research and company yearly reports, then bridges the gap with a tailored business model.
Industry & society
Manufacturers get product innovations they can build — and society gets the benefit of research that ships.
AI-matched opportunities
6 research outputs paired with industry partners.
A handheld sepsis triage kit that flags at-risk patients during intake, before lab results return — cutting time-to-antibiotics.
Razor-and-blade: MedTriage licenses the assay chemistry, sells a low-cost reader at near-cost, and earns recurring revenue on disposable strips priced per-test for emergency departments.
Earlier sepsis detection lowers ICU admissions and mortality, and the low per-test cost makes it viable for under-resourced regional hospitals.
An order portal where surgeons upload a CT scan and receive a patient-matched resorbable scaffold for complex reconstructions.
Mass-customisation on demand: OsteoForm prints per-patient scaffolds from uploaded scans, charging a per-case fee that bundles design, print and regulatory documentation.
Better-fitting scaffolds shorten recovery and reduce revision surgeries; resorbable material removes the need for hardware-removal operations.
An at-home Parkinson's tracking app that turns a weekly phone video into a progression dashboard shared with the patient's neurologist.
Prescribed digital therapeutic: Aurora integrates the model into a reimbursed app, billed to insurers per-patient-per-month for remote disease monitoring.
Remote monitoring reduces clinic visits for mobility-impaired patients and surfaces deterioration earlier, especially for rural populations.
A myoelectric hand with finger-level dexterity that retrains itself to the user over the first weeks of use.
Premium hardware + service: Cervo embeds the interface into a flagship prosthetic line and bundles ongoing calibration as a subscription.
Restores fine motor function for amputees, improving employability and independence; service model keeps devices current without full replacement.
A drop-in antimicrobial coating that catheter makers apply on existing lines, marketed as an infection-resistant product tier.
B2B2C ingredient brand: Helix co-develops and manufactures the coating, then supplies it as a certified material to catheter OEMs under a per-unit royalty.
Catheter-associated infections are among the most common hospital-acquired infections; reducing them cuts antibiotic use and length of stay.
A combination TB pill that revives existing antibiotics against resistant strains, shortening treatment regimens.
Reformulation + tiered pricing: Veridia develops a fixed-dose combination, protected by formulation IP, sold at differential prices across income tiers.
Tackling drug-resistant TB has outsized global-health impact; repurposing an off-patent molecule keeps the cost base low for endemic regions.